Cabot Corporation $CBT Position Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Cabot Corporation (NYSE:CBT) by 16.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 110,259 shares of the specialty chemicals company’s stock after acquiring an additional 15,561 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.21% of Cabot worth $10,014,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. acquired a new stake in shares of Cabot in the second quarter valued at approximately $633,302,000. Fuller & Thaler Asset Management Inc. grew its holdings in Cabot by 5.6% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after buying an additional 124,613 shares in the last quarter. State Street Corp grew its holdings in Cabot by 1.0% in the 4th quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock worth $134,256,000 after buying an additional 20,021 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Cabot by 4.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock valued at $131,253,000 after acquiring an additional 79,499 shares during the period. Finally, Bank of America Corp DE raised its stake in Cabot by 3.9% during the 3rd quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock valued at $128,032,000 after acquiring an additional 63,080 shares in the last quarter. 93.18% of the stock is owned by institutional investors and hedge funds.

Cabot Price Performance

Shares of NYSE CBT opened at $81.47 on Monday. Cabot Corporation has a twelve month low of $58.33 and a twelve month high of $94.53. The company has a current ratio of 1.47, a quick ratio of 0.97 and a debt-to-equity ratio of 0.48. The firm has a 50-day moving average of $86.67 and a two-hundred day moving average of $81.44. The company has a market capitalization of $4.21 billion, a price-to-earnings ratio of 22.95, a PEG ratio of 10.70 and a beta of 0.83.

Cabot (NYSE:CBT) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The business had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. During the same period in the previous year, the firm earned $1.90 EPS. The business’s revenue for the quarter was up 6.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, analysts expect that Cabot Corporation will post 6.35 earnings per share for the current fiscal year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Stockholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio is 53.24%.

Insider Buying and Selling at Cabot

In other news, CEO Sean Keohane sold 134,895 shares of the company’s stock in a transaction on Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at $34,351,390. This represents a 25.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Over the last three months, insiders sold 229,597 shares of company stock worth $19,646,746. Company insiders own 3.08% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. JPMorgan Chase & Co. increased their price target on Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research note on Friday, August 7th. Mizuho increased their target price on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. UBS Group dropped their price target on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 5th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. Finally, Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Two equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Cabot has an average rating of “Hold” and a consensus target price of $89.00.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.